Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 6391Neoplasms 5364Prostatic Neoplasms 2966Carcinoma, Non-Small-Cell Lung 2708Colorectal Neoplasms 2678Lung Neoplasms 2267Multiple Myeloma 1663Lymphoma 1600Neoplasm Metastasis 1551Leukemia, Myeloid, Acute 1539Melanoma 1486Pancreatic Neoplasms 1470Ovarian Neoplasms 1423Leukemia 1389Head and Neck Neoplasms 1284Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1127Leukemia, Lymphocytic, Chronic, B-Cell 1090Brain Neoplasms 1050Rectal Neoplasms 980Lymphoma, Follicular 979Recurrence 975Uterine Cervical Neoplasms 926Glioblastoma 920Carcinoma, Renal Cell 882Lymphoma, Large B-Cell, Diffuse 853Hodgkin Disease 777

Interventions

human papillomavirus vaccine, L1 type 16, 18 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Human Papillomavirus-Related Cervical Carcinoma × Clear all
NCT03728881 2025-08-03

PRIMAVERA

National Cancer Institute (NCI)

Phase 3 Completed
1,240 enrolled 107 charts
Gynecologic

Human Papillomavirus-Related Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡